Fatty liver induced by free radicals and lipid peroxidation

Free Radical Research

Volumn 46, Issue 6, 2012, Pages 758-765

  Morita, Mayuko ^a   Ishida, Noriko ^b   Uchiyama, Kazuhiko ^a   Yamaguchi, Kanji ^a   Itoh, Yoshito ^a   Shichiri, Mototada ^b   Yoshida, Yasukazu ^b   Hagihara, Yoshihisa ^b   Naito, Yuji ^a   Yoshikawa, Toshikazu ^a   Niki, Etsuo ^a,b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Fat liver; Free radical; HETE; HODE; Lipid peroxdation; NAFLD

Indexed keywords

AZO COMPOUND; DRINKING WATER; FREE RADICAL; HYDROXYICOSATETRAENOIC ACID; PHOSPHOLIPID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; LIPID COMPOSITION; LIPID DIET; LIPID LIVER LEVEL; LIPID PEROXIDATION; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN;

ANIMALS; DIET, HIGH-FAT; FATTY LIVER; FREE RADICALS; LIPID PEROXIDATION; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; PHOSPHOLIPIDS; TRIGLYCERIDES;

MUS;

EID: 84860738459     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2012.677840     Document Type: Article

References (44)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.
2. Bell LN, Molleston JP, Morton MJ, Klipsch A, Saxena R, Vuppalanchi R, et al. Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes. J Clin Gastroenterol 2011;45: 800-809.
3. Socha P, Horvath A, Vajro P, Dziechciarz P, Dhawan A, Szajewska H, et al. Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: A systematic review. J Pediatr Gastroenterol Nutr 2009;48:587-596.
4. Farrell GC. Non-alcoholic steatohapatitis: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 2003;18:124-138. (Pubitemid 36349857)
5. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998;114:842-845.
6. Feldstein AE, Lopez R, Tamimi TA, Yerian L, Chung YM, Berk M, et al. Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Lipid Res 2010;51:3046-3054.
7. Liu S, Shi W, Li G, Jin B, Chen Y, Hu H, et al. Plasma reactive carbonyl species levels and risk of non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2011;26:1010-1015.
8. Puri P, Wiest MM, Cheung O, Mirshahi F, Sargeant C, Min HK, et al. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 2009;50:1827-1838.
9. Konishi M, Iwasa M, Araki J, Kobayashi Y, Katsuki A, Sumida Y, et al. Increased lipid peroxidation in patients with nonalcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane. J Gastroenterol Hepatol 2006;21:1821-1825. (Pubitemid 44657003)
10. Erhardt A, Stahl W, Sies H, Lirussi F, Donner A, Hussinger D, et al. Plasma levels of vitamin E and carotenoids are decreased in patients with Nonalcoholic Steatohepatitis (NASH). Eur J Med Res 2011;16:76-78.
11. Chaikoff IL, Eichorn KB, Connor CL, Entenman C. The production of cirrhosis in the liver of the normal dog by prolonged feeding of a high fat diet. Am J Pathol 1943;19: 9-21.
12. Terao K, Niki E. Damage to biological tissues induced by radical initiator 2,2 ′-azobis(2-amidinopropane) dihydrochloride and its inhibition by chain-breaking antioxidants. J Free Radic Biol Med 1986;2:193-201. (Pubitemid 17045264)
13. Niki E, Takahashi M, Tsuchiya J, Komuro E, Ito E, Terao K, et al. Oxidation of lipids. XV. Role of hydrophilic diarylamines as antioxidants in the oxidations of lipids and biological tissues. Chem Biol Interact 1988;67:81-93.
14. Shimasaki H, Saypil WH, Ueta N. Free radical induced liver injury. II. Eff ects of intraperitoneally administered 2,2 ¢-azobis(2-amidinopropane) dihydrochloride on the fatty acid profiles of hepatic triacylglycerol and phospholipids. Free Radic Res Commun 1991;14:247-252.
15. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917.
16. Shirai N, Suzuki H, Tokairin S, Ehara H, Wada S. Dietary and seasonal eff ects on the dorsal meat lipid composition of Japanese (Silurus asotus) and Thai catfish (Clarias macrocephalus and hybrid Clarias macrocephalus and Clarias galipinus ). Comp Biochem Physiol A Mol Integr Physiol 2002;32:609-619. (Pubitemid 34607317)
17. Yoshida Y, Kodai S, Takemura S, Minamiyama Y, Niki E. Simultaneous measurement of F2-isoprostane, hydroxyoctadecadienoic acid, hydroxyeicosatetraenoic acid, and hydroxycholesterols from physiological samples. Anal Biochem 2008;379:105-115.
18. Liu W, Yin H, Ogawa-Akazawa Y, Yoshida Y, Niki E, Porter NA, et al. Ex vivo oxidation in tissue and plasma assays of hydroxyoctadecadienoates: Z,E/E,E stereoisomer ratios. Chem Res Toxicol 2010;23:986-995.
19. Niki E. Lipid peroxidation: physiological levels and dual biological eff ects. Free Radic Biol Med 2009;47:469-484.
20. Yoshida Y, Hayakawa M, Cynshi O, Jishage K, Niki E. Acceleration of lipid peroxidation in β-tocopherol transfer protein-knock out mice following the consumption of drinking water containing a radical initiator. J Oleo Sci 2008;57: 577-583.
21. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterrology 2001;120:1183-1192. (Pubitemid 32246672)
22. Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007;46:1081-1090. (Pubitemid 350144772)
23. Videla LA, Rodrigo R, Araya J, Poniachik J. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease. Free Radic Biol Med 2004;37:1499-1507. (Pubitemid 39349251)
24. Araya J, Rodrigo R, Videla LA, Thielemann L, Orellana M, Pettinelli P, et al. Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin Sci 2004;106: 635-643. (Pubitemid 38797577)
25. Mehta K, Van Thiel DH, Shah N, Mobarhan S. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev 2002;60:289-293. (Pubitemid 35025794)
26. Mantena SK, Vaughn DP, Andringa KK, Eccleston HB, King AL, Abrams GA, et al. High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo. Biochem J 2009;417:183-193.
27. Zhu MJ, Sun LJ, Liu YQ, Feng YL, Tong HT, Hu YH, et al. Blood F2-isoprostanes are significantly associated with abnormalities of lipid status in rats with steatosis. World J Gastroenterol 2008;14:4677-4683.
28. Matsuzawa N, Takamura T, Kurita S, Misu H, Ota T, Anto H, et al. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 2007;46: 1392-1403. (Pubitemid 350155521)
29. Noguchi N, Yamashita H, Hamahara J, Nakamura A, Kuhn H, Niki E, et al. The specificity of lipoxygenase-catalyzed lipid peroxidation and the eff ects of radical-scavenging antioxidants. Biol Chem 2002;383:619-626. (Pubitemid 34506299)
30. Mihaljeviń B, Tartaro I, Ferreri C, Chatgilialoglu C. Linoleic acid peroxidation vs. isomerization: a biomimetic model of free radical reactivity in the presence of thiols. Org Biomol Chem 2011;9:3541-3548.
31. Obara N, Fukushima K, Ueno Y, Wakui Y, Kimura O, Tamai K, et al. Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice. J Hepatol 2010;53:326-334.
32. Caro AA, Cederbaum AI. Oxidative stress, toxicology, and pharmacy of CYP2E1. Annu Rev Pharmacol Toxicol 2004; 44:27-42. (Pubitemid 38263832)
33. Aubert J, Begriche K, Knockaert L, Robin MA, Fromenty B. Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: Mechanisms and pathophysiological role. Clin Res Hepatol Gastroenterol 2011;35:630-637 [Epub ahead of print Jun 8]. PMID: 21664213.
34. Lieber CS. CYP2E1: from ASH to NASH. Hepatol Res 2004;28:1-11. (Pubitemid 38145781)
35. Wu D, Cederbaum AI. Oxidative stress mediated toxicity exerted by ethanol-inducible CYP2E1. Toxicol Appl Pharmacol 2005;207:70-76.
36. Arnold C, Konkel A, Fischer R, Schunck WH. Cytochrome P450-denendent metabolism of β-6 and β-3 long-chain polyunsaturated fatty acids. Pharmacol Report 2010;62: 536-547.
37. Fer M, Dreano Y, Lucas D, Coreos L, Salaun JP, Berthou F, et al. Metabolism of eicosapentaenoic and docosahexaenoic acid by recombinant human cytochromes P450. Arch. Biochem Biophys 2008;471:116-125.
38. Bell LC, Guengerich FP. Oxidation kinetics of ethanol by human cytochrome P450 2E1. Rate-limiting product release accounts for eff ects of isotopic hydrogen substitution and cytochrome b5 on steady-state kinetics. J Biol Chem 1997; 272:29643-29651. (Pubitemid 27508056)
39. Dongiovanni P, Fracanzani AL, Fargion S, Valenti L. Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target. J Hepatol 2011;55:920-932. PMID: 21718726.
40. Yoshida Y, Imai Y, Sawai Y, Saito Y, Cao J, Fukuda K, et a l. Hydroxyoctadecadienoic acid as a potential biomarker for oxidative stress in patients with chronic hepatitis C. J Gastroentertol Hepatol 2010;25:107-115.
41. Foster T, Budoff MJ, Saab S, Ahmadi N, Gordon C, Guerci AD, et al. Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial. Am J Gastroenterrol 2011;106:71-77.
42. AdlinolfiLE, Restivo L. Does vitamin E cure nonalcoholic steatohepatitis? Expert Rev Gastroentertol Hepatol 2011;5:147-150.
43. Raso GM, Esposito E, Iacono A, Pacilio M, Cuzzocrea S, Canani RB, et al. Comparative therapeutic eff ects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat. Eur J Pharmacol 2009;604:125-131.
44. Saypil WH, Shimasaki H, Ueta N. Free radical induced liver injury. I. Effects of dietary vitamin E deficiency on triacylglycerol level and its fatty acid profile in rat liver. Free Radic Res Commun 1991;14:315-322.